172 related articles for article (PubMed ID: 21572873)
1. Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation.
Grant WB
Dermatoendocrinol; 2009 Nov; 1(6):289-93. PubMed ID: 21572873
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update).
Newberry SJ; Chung M; Shekelle PG; Booth MS; Liu JL; Maher AR; Motala A; Cui M; Perry T; Shanman R; Balk EM
Evid Rep Technol Assess (Full Rep); 2014 Sep; (217):1-929. PubMed ID: 30313003
[TBL] [Abstract][Full Text] [Related]
3. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers.
Grant WB
J Photochem Photobiol B; 2010 Nov; 101(2):130-6. PubMed ID: 20570169
[TBL] [Abstract][Full Text] [Related]
4. Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?
Grant WB; Karras SN; Bischoff-Ferrari HA; Annweiler C; Boucher BJ; Juzeniene A; Garland CF; Holick MF
Dermatoendocrinol; 2016; 8(1):e1187349. PubMed ID: 27489574
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
6. Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate.
Grant WB
Dermatoendocrinol; 2012 Apr; 4(2):198-202. PubMed ID: 22928077
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines.
Grant WB
Dermatoendocrinol; 2011 Jul; 3(3):199-204. PubMed ID: 22110780
[TBL] [Abstract][Full Text] [Related]
11. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study.
Durup D; Jørgensen HL; Christensen J; Tjønneland A; Olsen A; Halkjær J; Lind B; Heegaard AM; Schwarz P
J Clin Endocrinol Metab; 2015 Jun; 100(6):2339-46. PubMed ID: 25710567
[TBL] [Abstract][Full Text] [Related]
12. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.
Moukayed M; Grant WB
Rev Endocr Metab Disord; 2017 Jun; 18(2):167-182. PubMed ID: 28213657
[TBL] [Abstract][Full Text] [Related]
13. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.
Tuohimaa P; Tenkanen L; Ahonen M; Lumme S; Jellum E; Hallmans G; Stattin P; Harvei S; Hakulinen T; Luostarinen T; Dillner J; Lehtinen M; Hakama M
Int J Cancer; 2004 Jan; 108(1):104-8. PubMed ID: 14618623
[TBL] [Abstract][Full Text] [Related]
14. Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries.
Grant WB; Juzeniene A; Moan JE
Scand J Public Health; 2011 Feb; 39(1):70-8. PubMed ID: 20817654
[TBL] [Abstract][Full Text] [Related]
15. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States.
Grant WB; Peiris AN
J Am Med Dir Assoc; 2010 Nov; 11(9):617-28. PubMed ID: 21029996
[TBL] [Abstract][Full Text] [Related]
16. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.
Vashi PG; Trukova K; Lammersfeld CA; Braun DP; Gupta D
Nutr J; 2010 Nov; 9():60. PubMed ID: 21092237
[TBL] [Abstract][Full Text] [Related]
17. Cloud cover-adjusted ultraviolet B irradiance and pancreatic cancer incidence in 172 countries.
Garland CF; Cuomo RE; Gorham ED; Zeng K; Mohr SB
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):257-63. PubMed ID: 25864626
[TBL] [Abstract][Full Text] [Related]
18. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study.
Durup D; Jørgensen HL; Christensen J; Schwarz P; Heegaard AM; Lind B
J Clin Endocrinol Metab; 2012 Aug; 97(8):2644-52. PubMed ID: 22573406
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease.
Klapdor S; Richter E; Klapdor R
Anticancer Res; 2012 May; 32(5):1991-8. PubMed ID: 22593477
[TBL] [Abstract][Full Text] [Related]
20. A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health.
Grant WB; Al Anouti F; Boucher BJ; Dursun E; Gezen-Ak D; Jude EB; Karonova T; Pludowski P
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35276999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
